Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.

OBJECTIVE To determine the incremental cost-effectiveness and net benefit of a depression collaborative care program compared with usual care for patients with diabetes and depression. RESEARCH DESIGN AND METHODS This article describes a preplanned subgroup analysis of patients with diabetes from the Improving Mood-Promoting Access to Collaborative (IMPACT) randomized controlled trial. The setting for the study included 18 primary care clinics from eight health care organizations in five states. A total of 418 of 1,801 patients randomized to the IMPACT intervention (n = 204) versus usual care (n = 214) had coexisting diabetes. A depression care manager offered education, behavioral activation, and a choice of problem-solving treatment or support of antidepressant management by the primary care physician. The main outcomes were incremental cost-effectiveness and net benefit of the program compared with usual care. RESULTS Relative to usual care, intervention patients experienced 115 (95% CI 72-159) more depression-free days over 24 months. Total outpatient costs were 25 dollars (95% CI -1,638 to 1,689) higher during this same period. The incremental cost per depression-free day was 25 cents (-14 dollars to 15 dollars) and the incremental cost per quality-adjusted life year ranged from 198 dollars (144-316) to 397 dollars (287-641). An incremental net benefit of 1,129 dollars (692-1,572) was found. CONCLUSIONS The IMPACT intervention is a high-value investment for older adults with diabetes; it is associated with high clinical benefits at no greater cost than usual care.

[1]  S. Norris,et al.  Depressive symptoms and mortality among persons with and without diabetes. , 2005, American journal of epidemiology.

[2]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  B. Druss,et al.  Transforming mental health care at the interface with general medicine: report for the presidents commission. , 2006, Psychiatric Services.

[4]  K. Freedland,et al.  Cognitive Behavior Therapy for Depression in Type 2 Diabetes Mellitus , 1998, Annals of Internal Medicine.

[5]  W. Katon,et al.  Increased medical costs of a population-based sample of depressed elderly patients. , 2003, Archives of general psychiatry.

[6]  L. Mynors-Wallis,et al.  Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care , 1995, BMJ.

[7]  Jürgen Unützer,et al.  Willingness to pay for depression treatment in primary care. , 2003, Psychiatric services.

[8]  N. Miller,et al.  Cost-Effectiveness of Psychotherapy: A Guide for Practitioners, Researchers, and Policymakers , 1999 .

[9]  Wayne Katon,et al.  Relationship of depression and diabetes self-care, medication adherence, and preventive care. , 2004, Diabetes care.

[10]  D. Rubin.  Multiple imputation for nonresponse in surveys , 1989 .

[11]  John C. Hershey,et al.  Carrier Screening for Cystic Fibrosis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  Xiao-Hua Zhou,et al.  Cost-effectiveness of improving primary care treatment of late-life depression. , 2005, Archives of general psychiatry.

[13]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[14]  W. Katon,et al.  Quality Adjusted Life Years in Older Adults With Depressive Symptoms and Chronic Medical Disorders , 2000, International Psychogeriatrics.

[15]  W. Katon,et al.  Diabetes complications and depression as predictors of health service costs. , 2005, General hospital psychiatry.

[16]  K. Freedland,et al.  Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. , 2000, Diabetes care.

[17]  D A Revicki,et al.  Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. , 1998, Journal of affective disorders.

[18]  J. Lave,et al.  Cost-effectiveness of treatments for major depression in primary care practice. , 1998, Archives of general psychiatry.

[19]  W. Katon,et al.  Cardiac risk factors in patients with diabetes mellitus and major depression , 2004, Journal of General Internal Medicine.

[20]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[21]  L. Phillips,et al.  Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment , 2003, Biological Psychiatry.

[22]  T. Patterson,et al.  Preliminary longitudinal assessment of quality of life in patients with major depression. , 1997, Psychopharmacology bulletin.

[23]  W. Katon,et al.  Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. , 2001, The American journal of psychiatry.

[24]  M. Hegel,et al.  Improving Primary Care for Depression in Late Life: The Design of a Multicenter Randomized Trial , 2001, Medical care.

[25]  Wayne Katon,et al.  Depression and diabetes symptom burden. , 2004, General hospital psychiatry.

[26]  C. Sherbourne,et al.  Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. , 1999, Archives of general psychiatry.

[27]  W. Katon,et al.  Potentially Modifiable Factors Associated With Disability Among People With Diabetes , 2005, Psychosomatic medicine.

[28]  Wayne Katon,et al.  The Effectiveness of Depression Care Management on Diabetes-Related Outcomes in Older Patients , 2004, Annals of Internal Medicine.

[29]  K. Markides,et al.  Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. , 2003, Diabetes care.

[30]  Evette Ludman,et al.  The association of comorbid depression with mortality in patients with type 2 diabetes. , 2005, Diabetes care.

[31]  R. Klein,et al.  The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[32]  W. Katon,et al.  Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. , 1997, JAMA.

[33]  W. Manning,et al.  Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. , 2001, Archives of general psychiatry.

[34]  L. Covi,et al.  The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. , 1974, Modern problems of pharmacopsychiatry.

[35]  W. Katon,et al.  Work disability among individuals with diabetes. , 2005, Diabetes care.